bioRxivPhysiology
Nanoparticle-mediated delivery of placental gene therapy via uterine artery catheterization in a pregnant rhesus macaque
J. Schmidt, R. Wilson, B. Davenport, T. Hacker, C. Fitz, H. A. Simmons, M. L. Schotzko, T. Golos, H. Jones
Abstract
Nanoparticles offer promise as a mechanism to non-invasively deliver targeted placental therapeutics. Our previous studies utilizing intraplacental administration demonstrate efficient nanoparticle uptake into placental trophoblast cells and overexpression of human IGF1 (hIGF1). Nanoparticle-mediated placental overexpression of hIGF1 in small animal models of placental insufficiency and fetal growth restriction improved nutrient transport and restored fetal growth. The objective of this pilot study was to extend these studies to the pregnant nonhuman primate and develop a method for local delivery of nanoparticles to the placenta via maternal blood flow from the uterine artery. Nanoparticles containing hIGF1 plasmid driven by the placenta-specific PLAC1 promoter were delivered to a mid-gestation pregnant rhesus macaque via a catheterization approach that is clinically used for uterine artery embolization. Maternal-fetal interface, fetal and maternal tissues were collected four days post-treatment to evaluate the efficacy of hIGF1 treatment in the placenta. The uterine artery catheterization procedure and nanoparticle treatment was well tolerated by the dam and fetus through the four-day study period following catheterization. Nanoparticles were taken up by the placenta from maternal blood as plasmid-specific hIGF1 expression was detected in multiple regions of the placenta via in situ hybridization and qPCR. The uterine artery catheterization approach enabled successful delivery of nanoparticles to maternal circulation in close proximity to the placenta with no concerns to maternal or fetal health in this short-term feasibility study. In the future, this delivery approach can be used for preclinical evaluation of the long-term safety and efficacy of nanoparticle-mediated placental therapies in a rhesus macaque model. HighlightsNovel method to deliver therapeutics to maternal-fetal interface Delivery of nanoparticles to the placenta via maternal catheterization
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Maternal, placental and fetal response to a non-viral, polymeric nanoparticle gene therapy in nonhuman primates
R. L. Wilson, J. Kropp Schmidt, … H. Jones·bioRxiv·Jun 16, 2023
- Nanoparticle-mediated transgene expression of insulin-like growth factor 1 in the growth restricted guinea pig placenta increases placenta nutrient transporter expression and fetal glucose concentrations
- Placental Nanoparticle-mediated IGF1 Gene Therapy Corrects Fetal Growth Restriction in a Guinea Pig Model
B. Davenport, R. Wilson, … H. Jones·bioRxiv·Apr 5, 2024
- Placental hIGF1 nanoparticle gene therapy in guinea pigs ameliorates fetal growth restriction-associated changes in hepatic lipid and glucose metabolism-related signaling pathways in a fetal sex-specific manner
Baylea N. Davenport, Alyssa Williams, … Rebecca L. Wilson·American Journal of Physiology-Endocrinology and MetabolismPeer-reviewed·Feb 5, 2025
- Maternal-fetal interfaces transcriptome changes associated with placental insufficiency and a novel gene therapy intervention
Helen N Jones, Baylea N. Davenport, Rebecca L. Wilson·Physiological GenomicsPeer-reviewed·Oct 7, 2024
- Mid-pregnancy placental transcriptome in a model of placental insufficiency with and without novel intervention
Rebecca L. Wilson, Baylea N. Davenport, Helen N Jones·Reproductive SciencesPeer-reviewed·Dec 20, 2024